Company: COOT
Filing Date: 2025-03-21
Form Type: DEF 14A
Source: 0001641172-25-000118
Chunk: 3

Company: Australian Oilseeds Holdings Ltd
Filing Date: 2025-03-21
Form: DEF 14A
Chunk 3
---
 board of directors
(the “Board” or “Board of Directors”) of Australian Oilseeds Holdings Limited (the “Company,” “Australian
Oilseeds,” “we,” “us,” or “our”), in connection with our 2025 annual meeting of shareholders
(the “Annual Meeting”). The Notice of Annual Meeting and this Proxy Statement are first being distributed or made available,
as the case may be, on or about April 4, 2025.

Explanatory Note

On March 21, 2024 (the “Closing Date”),
Australian Oilseeds consummated the previously announced business combination pursuant to the Business Combination Agreement, dated as
of December 5, 2022 (as amended on March 31, 2023 and December 7, 2023 (the “Business Combination Agreement”), between the
Company, EDOC Acquisition Corp., a Cayman Islands exempted company (“EDOC”), American Physicians LLC, a Delaware limited
liability company, in the capacity as the representative, from and after the Closing Date for the shareholders of Purchaser and the Company
(other than the Sellers (as defined below)) in accordance with the terms and conditions of the Business Combination Agreement (the “Purchaser
Representative”), AOI Merger Sub, a Cayman Islands exempted company and a wholly-owned subsidiary of the Company (“Merger
Sub”), Australian Oilseeds Investments Pty Ltd., an Australian proprietary company (“AOI”), Gary Seaton, in his capacity
as the representative for the Sellers, in accordance with the terms and conditions of the Business Combination Agreement (the “Seller
Representative”), and each of the holders of AOI’s outstanding ordinary shares named on Annex I to the Business Combination
Agreement (the “Sellers”). The transactions contemplated by the Business Combination Agreement are referred to herein as
the “Business Combination.”

Pursuant to the Business Combination Agreement, on
the Closing Date, EDOC merged with and into Merger Sub, with EDOC continuing as the surviving entity (the “Merger”), as a
result of which, EDOC became a wholly owned subsidiary of the Company, and each issued and outstanding security of EDOC prior to the
Closing Date was cancelled in exchange for the receipt of substantially identical securities of the Company. Also on the Closing Date,
the Company acquired all of the issued and outstanding ordinary shares of AOI (the “Purchased Shares”) from the Sellers in
exchange for the Company’s ordinary shares (“Company Ordinary